Skip to main content

Table 1 Patient characteristics

From: Premedication with intranasal dexmedetomidine decreases barbiturate requirement in pediatric patients sedated for magnetic resonance imaging: a retrospective study

 

Group

Dexmedetomidine (DEX)

Thiopental (THIO)

p-value

 

n

mean (SD)a

n

mean (SD)a

Age (yr)

ALL

100

4.50 (2.56)

100

4.06 (2.39)

0.22

 

0–2 years

20

1.21 (0.56)

24

1.24 (0.45)

 
 

2–6 years

50

3.93 (1.16)

53

3.85 (1.09)

 
 

6–11 years

30

7.64 (1.30)

23

7.47 (1.31)

 

Weight (kg)

ALL

100

18.8 (7.5)

100

17.4 (6.4)

0.19

 

0–2 years

20

10.3 (1.9)

24

10.5 (2.1)

 
 

2–6 years

50

17.4 (3.3)

53

17.0 (3.4)

 
 

6–11 years

30

26.8 (7.1)

23

25.6 (5.7)

 

BMI (kg/m2)

ALL

100

16.5 (2.2)

100

16.5 (1.8)

0.68

 

0–2 years

20

17.4 (2.1)

24

17.3 (2.2)

 
 

2–6 years

50

16.3 (2.0)

53

16.5 (1.6)

 
 

6–11 years

30

16.3 (2.4)

23

15.9 (1.7)

 

Duration of MRI (min)

ALL

100

43 (41–57)

100

47 (35–50)

0.001

 

0–2 years

20

43 (36–57)

24

49 (43–60)

0.124

 

2–6 years

50

42 (35–48)

53

46 (40–57)

0.002

 

6–11 years

30

43 (34–55)

23

50 (37–55)

0.804

  1. aMean and SD reported, except for duration of MRI, for which median and IQR are shown